Clearbridge Health

Healthcare

Healthcare stocks get a shot in the arm as Wuhan virus fears rise

Private outpatient medical service provider Healthway Medical Corporation led the way on Tuesday, surging 42.9% to a new 52-week-high of 4 cents as at 12pm. But other SGX-listed healthcare stocks are also on the rise.

Equity raising

Clearbridge Health in private placement to raise $11.3 mil to speed up Asia growth plans

SINGAPORE (July 29): Clearbridge Health is raising $11.34 million from a share placement exercise to accelerate its growth plans in Asia’s healthcare market.

M&A

Clearbridge acquires 89.6% stake in Indonesia's IGM Labs for $9.4 mil

SINGAPORE (Apr 3): Clearbridge Health is acquiring a 89.6% stake in IGM Labs of Indonesia for $9.4 million or 2.8 times its EV/EBITDA.

Healthcare

Clearbridge subsidiary to issue $2 mil in convertible bonds

SINGAPORE (Mar 25): Clearbridge Health Limited’s subsidiary, Clearbridge Biophotonics, is set to issue $2 million in convertible bonds to develop its proprietary computational imaging microscopy technology with the aim of commercialisation.  

IPO

Biolidics shares slump on Catalist debut

SINGAPORE (Dec 19): Just two hours into its debut on the Singapore Exchange (SGX) Catalist board, shares in medical technology firm Biolidics have slumped 23.2% from its listing price of 28 cents.

IPO

Biolidics selling 27.5 mil new shares at 28 cents each in conjunction with Catalist listing

SINGAPORE (Dec 11): Medtech company Biolidics is selling 27.5 million new shares at 28 cents each to retail and institutional investors in a private placement ahead of its listing on the Catalist Board of the Singapore Exchange.

In print this week

Clearbridge Health rides on China's biotech boom for cancer diagnostic spinoff

SINGAPORE (Aug 31): Investors and foreign biotech veterans are making their way to China as the government aims to build a healthcare empire.

M&A

Clearbridge enters MoU for expansion of lab testing services to Indonesia

SINGAPORE (Aug 23): Clearbridge Health’s wholly-owned subsidiary, SAM Laboratory, is acquiring a controlling stake in PT Indo Genesis Medika, a company incorporated in Indonesia, for an aggregate consideration of about IDR 40.7 billion ($3.8 million).

IPO

Clearbridge BioMedics receives $6.6 mil in pre-IPO funding ahead of targeted 4Q launch

SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.

M&A

Clearbridge Health acquires 85% stake in medical aesthetics clinic for $5.5 mil

SINGAPORE (Apr 3): Clearbridge Health, the recently listed healthcare group, announced that it has completed its acquisition of an 85% stake in Medic Surgical Private Limited (MSPL) and Medic Laser Private Limited (MLPL) for $5.5 million.
×